ATOSSA GENETICS INC Chart calendar Atossa Genetics Inc
c0460ed4d5b54c164.kD4WuJpcRLHaO0SPVCWWPAOrJUw0HdIXqWlprpes4IQ.ok5U1K0aLeufDBHbZ1-nVzL7RidfbrN_wAQT5_H2h_P7eHvz-RQb870OAQ~3929be2278bf2de75af5f2738059007f
Upcoming events on Atossa Genetics Inc
Past events on Atossa Genetics Inc
| 13/05/2024 13:50 | Q1 2024 Earnings Release |
| 01/05/2024 21:00 | Planet MicroCap Showcase |
| 17/04/2024 14:00 | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number: CT205 |
| 01/04/2024 21:00 | Q4 2023 Earnings Release |
| 20/02/2024 14:00 | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 13/11/2023 14:00 | Q3 2023 Earnings Release |
| 28/09/2023 14:10 | Cantor Global Healthcare Conference |
| 14/08/2023 17:31 | Q2 2023 Earnings Release |
| 14/08/2023 14:00 | Q2 2023 Earnings Call |
| 11/07/2023 15:00 | Virtual Investor Summer Spotlight Series |
| 21/06/2023 16:30 | Maxim Group Virtual Healthcare Conference |
| 04/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract No.: TPS633 Poster Bd# 454a |
| 15/05/2023 14:10 | Q1 2023 Earnings Release |
| 04/05/2023 16:00 | Investor Meeting - Fireside Chat |
| 04/05/2023 14:00 | Annual General Meeting |
| 23/03/2023 17:00 | Sidoti Spring Small-Cap Conference |
| 22/03/2023 20:05 | Q4 2022 Earnings Release |
| 07/11/2022 21:00 | Q3 2022 Earnings Release |
| 11/09/2022 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,3 -18,3 5.65% | -14,6 -15,0 2.82% | -20,5 -21,7 5.27% | -27,7 -27,8 0.5% | -31,4 -31,2 -0.56% | -33,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,2 -18,3 5.65% | -17,8 -15,0 -18.89% | -20,6 -21,8 5.27% | -27,0 -27,8 2.99% | -30,1 -30,2 0.19% | -32,4 |
|
Net income Million USD | Released Forecast Spread | -17,2 -18,3 5.65% | -17,8 -15,0 -18.89% | -20,6 -21,8 5.27% | -27,0 -27,8 2.99% | -30,1 -30,2 0.19% | -32,0 |
|
EPS USD | Released Forecast Spread | -2,03 -2,03 0% | -1,97 -1,21 -63.49% | -0,18 -0,19 2.7% | -0,21 -0,22 4.55% | -0,24 -0,24 0% | -0,25 |
| Announcement Date | 26/03/20 | 31/03/21 | 28/02/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,75 -7,00 32.19% | -6,60 -5,99 -10.06% | -8,21 -6,96 -17.85% | -8,14 -8,31 2.04% | -7,10 -8,00 11.28% | -7,79 -7,73 -0.86% | -7,47 -8,36 10.68% | -9,02 -8,09 -11.47% | -6,98 -8,67 19.46% | -8,15 | -8,64 | -9,31 | -8,50 | -8,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,79 -7,00 31.63% | -6,67 -5,99 -11.35% | -8,01 -6,96 -15.06% | -7,49 -8,31 9.83% | -6,28 -8,00 21.49% | -9,83 -7,73 -27.22% | -6,23 -8,36 25.5% | -7,75 -7,79 0.48% | -5,88 -8,30 29.18% | -8,15 | -8,64 | -9,31 | -8,50 | -8,50 |
|
Net income Million USD | Released Forecast Spread | -4,79 -7,00 31.63% | -6,67 -5,99 -11.35% | -8,01 -6,96 -15.06% | -7,49 -8,31 9.83% | -6,28 -8,00 21.49% | -9,83 -7,73 -27.22% | -6,23 -8,36 25.5% | -7,75 -7,79 0.48% | -5,88 -8,30 29.18% | -8,15 | -8,64 | -9,31 | -8,50 | -8,50 |
|
EPS USD | Released Forecast Spread | -0,04 -0,06 33.33% | -0,05 -0,05 0% | -0,06 -0,06 -9.09% | -0,06 -0,07 7.69% | -0,05 -0,06 16.67% | -0,08 -0,06 -33.33% | -0,05 -0,07 25% | -0,06 -0,06 0% | -0,05 -0,07 25% | -0,07 | -0,07 | -0,08 | -0,07 | -0,07 |
| Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 22/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 01/04/24 | 13/05/24 | - | - | - | - | - |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
Past sector events for Atossa Genetics Inc
| Today | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 13/05/2024 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 13/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
| 13/05/2024 21:30 | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 12:00 | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 00:00 | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
| 13/05/2024 11:30 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 13/05/2024 21:10 | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
